Clinical Trial Update: A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and effectiveness of MK0217 for preventing and treating osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• MK0217

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED